1
TITLE: LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab
AUTHORS: Natkunam, Y; Farinha, P; Hsi, ED; Hans, CP; Tibshirani, R; Sehn, LH; Connors, JM; Gratzinger, D; Rosado, M; Zhao, S; Pohlman, B; Wongchaowart, N; Bast, M; Avigdor, A; Schiby, G; Nagler, A; Byrne, GE; Levy, R; Gascoyne, RD; Lossos, IS;
PUBLISHED: 2008, SOURCE: Journal of Clinical Oncology, VOLUME: 26, ISSUE: 3
INDEXED IN: Scopus CrossRef